Post-Cycle Soft-Tissue Recovery Research Stack
Reviewed by the BestHealingPeptides Editorial Team ·
Investigate combined peptide effects on soft-tissue and cartilage repair in post-exercise and post-cycle recovery research models.
Components
BPC-157
tendon-ligament · gut-healing · anti-inflammatory · regeneration
TB-500
tendon-ligament · skin-wound · regeneration · anti-inflammatory
AOD-9604
regeneration · joint
Protocol notes
This stack is framed for the soft-tissue / cartilage recovery research literature, not for any clinical post-anabolic-cycle context. Researchers should declare the model rationale in protocol documents — the 'post-cycle' terminology has a grey-market connotation that this site does not endorse. AOD-9604 has cartilage research data through Phase IIb clinical work in adjacent indications; its inclusion alongside BPC-157 and TB-500 reflects this mechanistic complementarity rather than any combined human protocol.
Mechanistic rationale
BPC-157 has the deepest tendon and connective-tissue research record, with tenocyte and ligament-fibroblast effects mediated by growth-hormone-receptor and VEGFR2 pathways. TB-500 (the actin-binding thymosin beta-4 fragment) supports cell migration into injured connective tissue and provides angiogenic effects relevant to hypovascular tendon and cartilage healing. AOD-9604 brings cartilage-specific research data — including effects on chondrocyte proliferation and extracellular matrix synthesis documented in osteoarthritis models — and a documented Phase IIb safety record. The three peptides together address the soft-tissue and cartilage research domains that an exercise-recovery model is typically designed to capture, without overlapping wholesale with the dermal or gut-axis stacks.
Endpoint suggestions
Connective-tissue endpoints: tendon biomechanical load-to-failure, collagen-I/-III ratio, type-IIA collagen-marker expression in cartilage, hyaluronic acid synthase expression, and aggrecan content in articular cartilage biopsies. Imaging endpoints: T2 mapping of articular cartilage in larger-animal models. Functional endpoints: limb-loading recovery in tendon transection models. For exercise-recovery models, serum CK and inflammatory cytokines (IL-6, TNF-α) as systemic markers.
Confounders
Exercise dose, recovery interval, and pre-existing tissue conditioning all influence baseline healing signal. AOD-9604's lipolytic activity (the principal pharmacological effect of the hGH C-terminal fragment) may produce body-composition changes that confound interpretation of imaging endpoints in obese rodent models. Stack arms should include vehicle controls and consider single-agent comparators for each peptide. Subcutaneous administration of all three peptides into the same site can produce local irritation — rotate injection sites and document any local reactions.
Where to source research peptides for laboratory research
The following UK-based suppliers stock research-grade, lyophilised peptides for in-vitro and pre-clinical work. Purity and provenance vary; always request a Certificate of Analysis (CoA) and confirm cold-chain storage on arrival. None of the products linked below are approved for human use.
- PeptideAuthority.co.uk
UK-based research peptide supplier with batch certificates of analysis and >99% purity testing.
- PeptideBarn.co.uk
Wide catalogue of research-grade lyophilised peptides shipped from the UK, including bulk vials.